or
forgot password

    • cancer clinical trials in concord, NH

    • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Dartmouth - Hitchcock Concord
    Concord, New Hampshire 03301
    Breast Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer
    Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Metastatic Cancer, Prostate Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Dartmouth - Hitchcock Concord
    Concord, New Hampshire 03301
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Payson Center for Cancer Care at Concord Hospital
    Concord, New Hampshire 03301
    Breast Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lymphoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Metastatic Cancer, Prostate Cancer
    Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lymphoma
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Colorectal Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer
    Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Esophageal Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Dartmouth - Hitchcock Concord
    Concord, New Hampshire 03301
    Prostate Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer
    Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Prostate Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Prostate Cancer
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    The Active After Cancer Trial (AACT)
    New Hampshire Oncology Hematology
    Concord, New Hampshire 03106
    Breast Cancer, Colorectal Cancer
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lymphoma
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Payson Center for Cancer Care at Concord Hospital
    Concord, New Hampshire 03301
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Colorectal Cancer
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Payson Center for Cancer Care at Concord Hospital
    Concord, New Hampshire 03301
    Esophageal Cancer
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer, Fatigue, Sleep Disorders
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Brain and Central Nervous System Tumors
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Brain and Central Nervous System Tumors
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
    Payson Center for Cancer Care at Concord Hospital
    Concord, New Hampshire 03301
    Metastatic Cancer, Pain
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Payson Center for Cancer Care at Concord Hospital
    Concord, New Hampshire 03301
    Prostate Cancer, Sexual Dysfunction
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lung Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Kidney Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Colorectal Cancer
    Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Lymphoma
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
    Payson Center for Cancer Care at Concord Hospital
    Concord, New Hampshire 03301
    Dysphagia, Lung Cancer, Pain, Esophagitis
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Payson Center for Cancer Care at Concord Hospital
    Concord, New Hampshire 03301
    Head and Neck Cancer, Precancerous Condition
    T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
    New Hampshire Oncology-Hematology, PA
    Concord, New Hampshire 03301
    Breast Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Dartmouth - Hitchcock Concord
    Concord, New Hampshire 03301
    Brain and Central Nervous System Tumors
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
    Concord, New Hampshire 03301
    Breast Cancer